PL4065134T3 - Doustne podawanie bursztynianu żelaza do stosowania w leczeniu niedoboru żelaza u pacjentów z niewydolnością serca - Google Patents

Doustne podawanie bursztynianu żelaza do stosowania w leczeniu niedoboru żelaza u pacjentów z niewydolnością serca

Info

Publication number
PL4065134T3
PL4065134T3 PL20812152.5T PL20812152T PL4065134T3 PL 4065134 T3 PL4065134 T3 PL 4065134T3 PL 20812152 T PL20812152 T PL 20812152T PL 4065134 T3 PL4065134 T3 PL 4065134T3
Authority
PL
Poland
Prior art keywords
iron
patients
oral administration
heart failure
succinate
Prior art date
Application number
PL20812152.5T
Other languages
English (en)
Inventor
Kurt BOMAN
Mona OLOFSSON
Original Assignee
Double Bond Pharmaceutical AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Double Bond Pharmaceutical AB filed Critical Double Bond Pharmaceutical AB
Publication of PL4065134T3 publication Critical patent/PL4065134T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20812152.5T 2019-11-26 2020-11-18 Doustne podawanie bursztynianu żelaza do stosowania w leczeniu niedoboru żelaza u pacjentów z niewydolnością serca PL4065134T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1951352 2019-11-26
PCT/SE2020/051104 WO2021107835A1 (en) 2019-11-26 2020-11-18 Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure

Publications (1)

Publication Number Publication Date
PL4065134T3 true PL4065134T3 (pl) 2024-03-04

Family

ID=73554483

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20812152.5T PL4065134T3 (pl) 2019-11-26 2020-11-18 Doustne podawanie bursztynianu żelaza do stosowania w leczeniu niedoboru żelaza u pacjentów z niewydolnością serca

Country Status (7)

Country Link
US (1) US12458666B2 (pl)
EP (1) EP4065134B1 (pl)
DK (1) DK4065134T3 (pl)
ES (1) ES2968183T3 (pl)
FI (1) FI4065134T3 (pl)
PL (1) PL4065134T3 (pl)
WO (1) WO2021107835A1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774291B1 (fr) * 1998-02-03 2000-04-21 Innothera Lab Sa Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element

Also Published As

Publication number Publication date
DK4065134T3 (da) 2024-01-22
FI4065134T3 (fi) 2024-01-11
EP4065134A1 (en) 2022-10-05
US12458666B2 (en) 2025-11-04
EP4065134B1 (en) 2023-12-20
ES2968183T3 (es) 2024-05-08
US20220395530A1 (en) 2022-12-15
WO2021107835A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
LT4243825T (lt) Omekamtivo mekarbilis, skirtas širdies nepakankamumo gydymui pasirinktose pacientų grupėse
IL275754A (en) Compounds, compositions, and methods for treating diseases involving infected acidic or hypoxic tissues
MX344329B (es) Formulación de una combinación de dronedarona y ranolazina para la manufactura de un medicamento para tratar fibrilación atrial.
MX2022011334A (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert.
IL260955A (en) A mini tablet for oral administration containing sacubitril and valsartan for the treatment of heart failure
ZA201705874B (en) Nk-3 receptor antagonists for therapeutic or cosmetic treatment of excess body fat
HK1202776A1 (en) Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
AR103118A1 (es) Tratamientos médicos basados en anamorelina
ZA202307367B (en) Intradialytic use of sodium nitrite
SG11202108488SA (en) Istaroxime-containing intravenous formulation for the treatment of acute heart failure (ahf)
TN2015000480A1 (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
IL325238A (en) Semaglutide in medical treatment
MX2022005032A (es) Terapia secuencial anti cumulo de diferenciacion 19 (cd19).
IL288678A (en) Treatment of heart failure in human subjects
MY200960A (en) Treatments For Heart Failure And Cardiac Ischaemic Reperfusion Injury
EP4486344A4 (en) ORAL PCLX-001 IN THE TREATMENT OF CANCER IN HUMANS
PL4065134T3 (pl) Doustne podawanie bursztynianu żelaza do stosowania w leczeniu niedoboru żelaza u pacjentów z niewydolnością serca
HUE072558T2 (hu) 1-Metil-1H-pirazol-3-il származékok neovaszkuláris betegségek kezelésében való alkalmazásra
PL4188327T3 (pl) Terapia skojarzona do podawania wziewnego
MX370451B (es) Cloruro de dietil-[6-(4-hidroxicarbamoil-fenil-carbamoiloxi metil)-naftalen-2-il-metil]-amonio para su uso en el tratamiento de distrofia muscular.
PL3937948T3 (pl) Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu chorób nerwowo-mięśniowych
MX2019015448A (es) Metodo para la prevencion de trombosis de desviacion de la arteria sistemica a pulmonar.
GB202202828D0 (en) Garment for therapeutic treatment
MX2021007324A (es) Terapia oral con acido 6,8-bis-benciltio-octanoico.
HK40080669A (en) Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients